Taurolidine-citrate line locks prevent recurrent CLABSI

0

Taurolidine-Citrate locks significantly reduced the rate of CLABSI, particularly Gram negative organisms without adverse events” Clark et al (2018).

Abstract:
This study describes a successful, targeted intervention in central venous access device routine care, to decrease central line associated bloodstream infection (CLABSI). Taurolidine-Citrate locks significantly reduced the rate of CLABSI, particularly Gram negative organisms without adverse events.

You may also be interested in…





Reference:

Clark, J., Graham, N., Kleidon, T. and Ullman, A. (2018) Taurolidine-Citrate Line Locks Prevent Recurrent Central Line Associated Bloodstream Infection in Pediatric Patients. The Pediatric Infectious Disease Journal. September 10th. .

doi: 10.1097/INF.0000000000002191.

Share.

Comments are closed.